Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems

Guardado en:

Detalles Bibliográficos
Publicado:	2008
Materias:	aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis
Acceso en línea:	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02699370_v22_n15_p2046_Toibaro http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	paper:paper_02699370_v22_n15_p2046_Toibaro
record_format	dspace
spelling	paper:paper_02699370_v22_n15_p2046_Toibaro2023-06-08T15:24:36Z Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis 2008 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02699370_v22_n15_p2046_Toibaro http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis
spellingShingle	aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
topic_facet	aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis
title	Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
title_short	Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
title_full	Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
title_fullStr	Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
title_full_unstemmed	Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
title_sort	pharmacokinetics interaction studies between rifampicin and protease inhibitors: methodological problems
publishDate	2008
url	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02699370_v22_n15_p2046_Toibaro http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro
_version_	1768542838163767296